{"nct_id":"NCT04597632","title":"An Extension Study Assessing the Efficacy and Safety of Brolucizumab in a Treat-to-Control Regimen in Patients With Neovascular Age-related Macular Degeneration Who Have Completed the CRTH258A2303 (TALON) Study","status":"COMPLETED","status_verified_date":"2024-10","start_date":"2020-12-16","start_date_type":"ACTUAL","primary_completion_date":"2023-03-28","primary_completion_date_type":"ACTUAL","completion_date":"2023-03-28","completion_date_type":"ACTUAL","phases":["PHASE3"],"tickers":["NVS"]}